Global Influenza Market Is Expected to Reach to USD 6.87 Billion by 2020, Growing at a CAGR of 8.33% Between 2017 and 2020
The Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H7N9 Subtype Infections – Pipeline Review, H2 2016, provides an overview of the Influenza A Virus report provides comprehensive information on the therapeutics under development for Neuropathic Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. Avian influenza A(H7N9) is a subtype of influenza viruses that have been detected in birds in the past.
View full press release